FDA Adverse Event Data Reveal Distinct Safety Profiles for Feline Diabetes Drugs Bexagliflozin and Velagliflozin
A pharmacovigilance analysis of nearly 6,000 FDA adverse event reports reveals that the two FDA-approved oral SGLT2 inhibitors for feline ...
